Chagas Disease (CD), caused by the protozoan Trypanosoma cruzi (T. cruzi), is considered
one of the thirteen main neglected tropical diseases that still afflicts many Latin American …

RESUMO Objetivo: Conhecer o manejo de pacientes com Doença de Chagas (DC) por
médicos da Atenção Primária Saúde (APS) de regiões endêmicas. Método: Estudo transversal …

SciELO - Brasil - Reações adversas ao benzonidazol no tratamento da Doença de Chagas:
revisão sistemática de ensaios clínicos randomizados e controlados Reações adversas ao …

Background The effectiveness of anti-parasite treatment with benznidazole in the chronic
Chagas disease (ChD) remains uncertain. We evaluated, using data from the NIH-sponsored …

Purpose We have established a prospective cohort of 1959 patients with chronic Chagas
cardiomyopathy to evaluate if a clinical prediction rule based on ECG, brain natriuretic peptide (…

Background: There are few contemporary cohorts of Trypanosoma cruzi–seropositive
individuals, and the basic clinical epidemiology of Chagas disease is poorly understood. Herein, …

Background Risk stratification of Chagas disease patients in the limited‐resource setting
would be helpful in crafting management strategies. We developed a score to predict 2‐year …

Background Trypanosoma cruzi parasite, the causative agent of Chagas disease, infects
about six million individuals in more than 20 countries. Monitoring parasite persistence in …

The present study aims to investigate how the social context contributes to the prognosis of
Chagas disease (CD). This is a multilevel study that considered individual and contextual …

Background Treatment with benznidazole for chronic Chagas disease is associated with
low cure rates and substantial toxicity. We aimed to compare the parasitological efficacy and …